LENZ Therapeutics (LENZ) Non Operating Income (2020 - 2026)
LENZ Therapeutics' Non Operating Income was $1.95 million in Q3 2026, down 10.9% from $2.19 million a year earlier and down 13.6% from the prior quarter.
Powered by 
Analysis
LENZ Therapeutics (LENZ) Non Operating Income (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, LENZ Therapeutics' Non Operating Income was $9.42 million through Sep 30, 2026, down 1.0% year-over-year; for FY2025, it was $9.51 million, up 7.6% from FY2024.
- In earlier years, Non Operating Income was $8.84 million in FY2024 (+287.5%), $2.28 million in FY2023 (-50.3%), $4.59 million in FY2022 and -$10.32 million in FY2021.
- The Q3 2026 figure marks the lowest quarterly Non Operating Income since Q1 2024.
- Compared with a year earlier, Non Operating Income was higher in two of the last seven quarters, with growth averaging 9.4%.
- The best year-over-year quarter for Non Operating Income over five years was Q3 2024 (growth of 177.2%); the worst was Q2 2023 (a decline of 72.3%).
- Per Business Quant data, LENZ's Non Operating Income in the three quarters before Q3 2026 was $2.26 million (Q2 2026), $2.65 million (Q1 2026) and $2.57 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | LENZ Therapeutics | 128.82 Mn | -839.21 Mn | 2.93 Mn | 1.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.95 Mn |
| Jun 30, 2026 | 2.26 Mn |
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | 2.57 Mn |
| Sep 30, 2025 | 2.19 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.73 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | -560,000.00 |
| Dec 31, 2023 | 1.12 Mn |
| Sep 30, 2023 | 985,000.00 |
| Jun 30, 2023 | 233,000.00 |
| Mar 31, 2023 | -54,000.00 |
| Dec 31, 2022 | 2.15 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 840,000.00 |
| Mar 31, 2022 | 123,000.00 |
| Dec 31, 2021 | 10,000.00 |
API Access
LENZ Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=LENZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "LENZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=LENZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();